Cargando…

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma

Esophageal squamous carcinoma (ESCC) has a high morbidity and mortality rate. Identifying risk metabolites associated with its progression is essential for the early prevention and treatment of ESCC. A total of 373 ESCC, 40 esophageal squamous dysplasia (ESD), and 218 healthy controls (HC) subjects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Mengjie, Wen, Wei, Yi, Xin, Zhu, Wei, Aa, Jiye, Wang, Guangji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859148/ https://www.ncbi.nlm.nih.gov/pubmed/35198450 http://dx.doi.org/10.3389/fonc.2022.829350

Ejemplares similares

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma
por: Chen, Zhongjian, et al.
Publicado: (2020)

RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma
por: Liu, Tiejun, et al.
Publicado: (2022)

Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
por: Yang, Xiao-li, et al.
Publicado: (2022)

Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms
por: Zheng, Deqiang, et al.
Publicado: (2019)

Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma
por: Ju, Mengyang, et al.
Publicado: (2022)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Gu, Yi-Min, et al.
Publicado: (2021)

Effect of circumferential resection margin status on survival and recurrence in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
por: Gu, Yi-Min, et al.
Publicado: (2022)

Identification of Biomarkers for Methamphetamine Exposure Time Prediction in Mice Using Metabolomics and Machine Learning Approaches
por: Sheng, Wei, et al.
Publicado: (2022)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma
por: Soares-Lima, Sheila Coelho, et al.
Publicado: (2021)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma
por: Zuo, Lihua, et al.
Publicado: (2021)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
por: Lv, Jiali, et al.
Publicado: (2021)

Comparative Genomic Analysis Reveals Genetic Variations in Multiple Primary Esophageal Squamous Cell Carcinoma of Chinese Population
por: Liang, Jinxiao, et al.
Publicado: (2022)

(1)H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer
por: Ouyang, Ting, et al.
Publicado: (2023)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment
por: Cui, Yiyao, et al.
Publicado: (2021)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Salivary Metabolomics for Prognosis of Oral Squamous Cell Carcinoma
por: Ishikawa, Shigeo, et al.
Publicado: (2022)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Identification of CHRNB4 as a Diagnostic/Prognostic Indicator and Therapeutic Target in Human Esophageal Squamous Cell Carcinoma
por: Li, Nan, et al.
Publicado: (2020)

Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
por: He, Jinxian, et al.
Publicado: (2023)

CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma
por: Zhou, Suna, et al.
Publicado: (2020)

Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform
por: Liu, Ran, et al.
Publicado: (2013)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
por: Ji, Wenbing, et al.
Publicado: (2021)

Comparison of PD-1 Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma in the Second-Line Setting
por: Zhou, Yi-Xin, et al.
Publicado: (2021)

Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
por: Mangalaparthi, Kiran K., et al.
Publicado: (2020)

Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Cui, Yuantao, et al.
Publicado: (2017)

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma
por: Jiao, Zichen, et al.
Publicado: (2020)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Corrigendum: CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

Integrative Multi−Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma
por: Wan, Zhengqing, et al.
Publicado: (2022)

Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kkaat4dcnkbcfmpb8qhngvnc39